Monoclonal B lymphocytes in multiple myeloma.

Area of Science:

• Immunology
• Oncology
• Hematology

Background:

• Multiple myeloma is characterized by monoclonal immunoglobulin production by malignant plasma cells.
• Understanding the B-lymphocyte origin and differentiation in myeloma is crucial for targeted therapies.

Purpose of the Study:

• To investigate the presence and characteristics of idiotype (Id) determinants on B lymphocytes in multiple myeloma patients.
• To explore the relationship between Id expression, immunoglobulin chains, and cell surface markers.

Main Methods:

• Raised individual-specific antisera against monoclonal immunoglobulin components from six IgG myeloma patients.
• Utilized direct and indirect immunofluorescence (IFL) to detect Id determinants on B lymphocytes and other blood cells.

Main Results:

• Id determinants were detected on B lymphocytes in five of six active multiple myeloma patients.
• Id determinants were absent in one patient with abnormal immunoglobulin heavy and light chain expression.
• Monoclonal B lymphocytes expressed Id structures along with gamma heavy chains, and sometimes mu and/or delta chains.
• Lymphoplasmacytoid cells in two patients expressed IgG with Id determinants intracellularly and on the surface.
• Fc receptors were more common on surface Id-expressing cells than on cytoplasmic Id-expressing cells.

Conclusions:

• The findings support the hypothesis of multiple myeloma as a differentiating B-lymphocyte tumor.
• Idotype expression on B cells provides insights into the B-cell origin and maturation stages in multiple myeloma.